Trials / Completed
CompletedNCT03231293
Fimasartan Blood Pressure Lowering After Acute Stroke
A Multicenter Longitudinal Observational Study to Assess the Effectiveness of Fimasartan-based Antihypertensive Treatment and Prognosis in Post-Acute Phase of Ischemic Stroke or Transient Ischemic Attack
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,035 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.
Conditions
Timeline
- Start date
- 2016-07-28
- Primary completion
- 2018-11-02
- Completion
- 2019-04-05
- First posted
- 2017-07-27
- Last updated
- 2019-11-04
Locations
27 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03231293. Inclusion in this directory is not an endorsement.